LIBTAYO
LIBTAYO
Discontinued
DIN Number
02487152
Drug Class
Human
Market Date
May 24, 2019
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02487152
AIG Number0161350001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FF06 CEMIPLIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CEMIPLIMABActive
Strength: 250 MG / 5 ML
Monograph: CEMIPLIMAB